Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis: results of the worldwide, cross-sectional ASAS-PerSpa study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Consenso ASAS en nomenclatura en español para las espondiloartritis (2018)
https://pubmed.ncbi.nlm.nih.gov/30193774/

Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASA-COMOSPA Study (2018)
https://pubmed.ncbi.nlm.nih.gov/29247152/

Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology (2016)
https://pubmed.ncbi.nlm.nih.gov/26573206/

Prevalence of comorbidities and evaluation of their screenin in spondyloarthitis: results of the international cross-sectional ASAS-COMOSPA study (2016)
https://pubmed.ncbi.nlm.nih.gov/26489703/

Secukinumab: a promising therapeutic option in spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27437696/

Prevalence of Psoriatic arthritis in psorisis patients according to newer classification criteria. Clin Rheumatol 2014;33:243-246 (2014)
https://pubmed.ncbi.nlm.nih.gov/24150746/